Advertisement

 

 

Sulfotyrosine dipeptide: Synthesis and evaluation as HIV-entry inhibitor.

Sulfotyrosine dipeptide: Synthesis and evaluation as HIV-entry inhibitor.
Author Information (click to view)

Ju T, Hu D, Xiang SH, Guo J,


Ju T, Hu D, Xiang SH, Guo J, (click to view)

Ju T, Hu D, Xiang SH, Guo J,

Advertisement
Share on FacebookTweet about this on TwitterShare on LinkedIn

Bioorganic chemistry 2016 7 2568() 105-111 pii 10.1016/j.bioorg.2016.07.012

Abstract

Human immunodeficiency virus type 1 (HIV-1) is responsible for the worldwide AIDS pandemic. Due to the lack of prophylactic HIV-1 vaccine, drug treatment of the infected patients becomes essential to reduce the viral load and to slow down progression of the disease. Because of drug resistance, finding new antiviral agents is necessary for AIDS drug therapies. The interaction of gp120 and co-receptor (CCR5/CXCR4) mediates the entry of HIV-1 into host cells, which has been increasingly exploited in recent years as the target for new antiviral agents. A conserved co-receptor binding site on gp120 that recognizes sulfotyrosine (sTyr) residues represents a structural target to design novel HIV entry inhibitors. In this work, we developed an efficient synthesis of sulfotyrosine dipeptide and evaluated it as an HIV-1 entry inhibitor.

Submit a Comment

Your email address will not be published. Required fields are marked *

two + nineteen =

[ HIDE/SHOW ]